A Study of Brenipatide in Participants With Major Depressive Disorder (RENEW-MDD-3)
A Phase 2, Multicenter, Randomized, Double-blind, Parallel-arm Study to Investigate the Efficacy and Safety of Adjunctive Treatment With Brenipatide Compared With Placebo in Adult Participants With Major Depressive Disorder Who Have Partial Response to Antidepressant Therapy (RENEW-MDD-3)
This study evaluates the safety and efficacy of brenipatide (LY3537031) as an add on therapy in participants with major depression who still have symptoms while taking a stable dose of standard of care anti-depressant medicine.
The study will last approximately 5 months.
研究概览
研究类型
注册 (估计的)
阶段
- 阶段2
联系人和位置
学习联系方式
- 姓名:Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or
- 电话号码:1-317-615-4559
- 邮箱:LillyTrials@Lilly.com
研究联系人备份
- 姓名:Physicians interested in becoming principal investigators please contact
- 邮箱:clinical_inquiry_hub@lilly.com
学习地点
-
-
-
Pleven、保加利亚、5800
- UMHAT Dr Georgi Stranski
-
首席研究员:
- Maya Stoimenova-Popova
-
Plovdiv、保加利亚、4004
- Medical Center MentalCare
-
首席研究员:
- Stanka Yazova
-
Sofia、保加利亚、1000
- Mental Health Center - Sofia EOOD
-
首席研究员:
- Emil Grashnov
-
Varna、保加利亚、9020
- DCC Mladost-M Varna OOD
-
首席研究员:
- Hristo Kozhuharov
-
Vratsa、保加利亚、3001
- Mental Health Center - Vratsa
-
首席研究员:
- Nadya Ivanova
-
-
-
-
-
Budapest、匈牙利、1033
- Clinexpert Gyöngyös
-
首席研究员:
- Tiberiu Dina
-
Gyöngyös、匈牙利、3200
- Clinexpert Gyöngyös
-
首席研究员:
- Anita Kiss
-
-
-
-
-
Bialystok、波兰、15-404
- MłynowaMed Specialist Psychiatric Medical Practice Joanna Łazarczyk
-
首席研究员:
- Joanna Lazarczyk
-
Bialystok、波兰、15-464
- Wlokiennicza Praktyka Lekarska dr n. med. Tomasz Markowski
-
首席研究员:
- Tomasz Markowski
-
Bydgoszcz、波兰、85-133
- Promente - Center of Neurology and Psychogeriatrics
-
首席研究员:
- Katarzyna Lachut
-
Gdansk、波兰、80-211
- Gdanski Uniwersytet Medyczny
-
首席研究员:
- Karol Grabowski
-
Gdansk、波兰、80-546
- Penta Hospitals Badania Kliniczne - Gdańsk 1
-
首席研究员:
- Katarzyna Binkowska-Michalik
-
Lodz、波兰、91 495
- AmiCare Sp. z o.o. Sp. K.
-
首席研究员:
- Katarzyna Przybyłowska- Kustosik
-
Lublin、波兰、20-064
- Instytut Naukowo-Badawczy w Lublinie Sp. z o.o.
-
首席研究员:
- Grzegorz Opielak
-
Olkusz、波兰、32-300
- Nowy Szpital w Olkuszu
-
首席研究员:
- Katarzyna Urbańczyk-Łosień
-
Rybnik、波兰、44-200
- M2M Med Badania Sp. Z o.o
-
首席研究员:
- Wojciech Eysymontt
-
Suchy Las、波兰、62-002
- Indywidualna Specjalistyczna Praktyka Lekarska Agnieszka Remlinger-Molenda
-
首席研究员:
- Agnieszka Remlinger
-
Warsaw、波兰、02-957
- IPIN Warsaw - Instytut Psychiatrii i Neurologii w Warszawie (IPIN)
-
首席研究员:
- Adam Wichniak
-
-
-
-
-
Bragadiru、罗马尼亚、077025
- Ames Research Center S.R.L.
-
首席研究员:
- Dan Rosu
-
Bucharest、罗马尼亚、41914
- Prof. Dr. Alexandru Obregia Psychiatry Hospital
-
首席研究员:
- Adela Ciobanu
-
Bucharest、罗马尼亚、031441
- Futuremeds - București
-
首席研究员:
- Alexandru Pavel
-
Bucharest、罗马尼亚、020744
- Clinic Nutrimed Cercetare S.R.L.
-
首席研究员:
- Marian Onofreiu
-
Galati、罗马尼亚、800179
- Spitalul De Psihiatrie Elisabeta- Domna- Galati
-
首席研究员:
- Claudiu Ionut Vasile
-
Galati、罗马尼亚、800183
- FutureMeds SRL - Galati
-
首席研究员:
- Mihai Mutica
-
-
-
-
Arizona
-
Phoenix、Arizona、美国、85012
- IMA Clinical Research - Phoenix
-
首席研究员:
- Payam Sadr
-
-
California
-
Chino、California、美国、91710
- Inland Psychiatric Medical Group
-
首席研究员:
- Nandita Puchakayala
-
Montclair、California、美国、91763
- Catalina Research Institute, LLC
-
首席研究员:
- Stephen Volk
-
Oceanside、California、美国、92056
- Excell Research
-
首席研究员:
- Sherry Soefje
-
Sherman Oaks、California、美国、91403
- California Neuroscience Research Medical Group, Inc.
-
首席研究员:
- Iman Parhami
-
West Hills、California、美国、91307
- Alliance Clinical West Hills
-
首席研究员:
- Clifford Feldman
-
-
Florida
-
Hollywood、Florida、美国、33021-6758
- The Medici Medical Research
-
首席研究员:
- Yesenia Kuan
-
Hollywood、Florida、美国、33024
- Research Centers of America, LLC-Hollywood
-
首席研究员:
- Edwin Gomez
-
Jacksonville、Florida、美国、32256
- Clinical Neuroscience Solutions, Inc. dba CNS Healthcare
-
首席研究员:
- Nandita Jones
-
Orlando、Florida、美国、32807
- Combined Research Orlando Phase I-IV LLC
-
首席研究员:
- Eric Carbonell
-
Plant City、Florida、美国、33563
- Denali Health - Plant City, FL
-
首席研究员:
- Walid Aziz
-
Tampa、Florida、美国、33613
- ForCare Clinical Research
-
首席研究员:
- Marlene Hart
-
West Palm Beach、Florida、美国、33407
- Neuroscience Research Institute - West Palm Beach
-
首席研究员:
- Danesh Alam
-
-
Georgia
-
Atlanta、Georgia、美国、30331
- Atlanta Center for Medical Research
-
首席研究员:
- Elyssa Barron
-
Atlanta、Georgia、美国、30328
- Synexus Clinical Research
-
首席研究员:
- Bethany Davis
-
Decatur、Georgia、美国、30030
- CenExel iResearch, LLC
-
首席研究员:
- Saundra Maass Robinson
-
Savannah、Georgia、美国、31405
- CenExel iResearch, LLC
-
首席研究员:
- Michael Mobley
-
-
Massachusetts
-
Boston、Massachusetts、美国、02131
- Boston Clinical Trials
-
首席研究员:
- Irina Mezhebovsky
-
Boston、Massachusetts、美国、02116
- Adams Clinical Boston
-
首席研究员:
- Darin Dougherty
-
Watertown、Massachusetts、美国、02472
- Adams Clinical
-
首席研究员:
- Stephanie Ellickson
-
-
Nevada
-
Las Vegas、Nevada、美国、89102
- IMA Clinical Research Las Vegas
-
首席研究员:
- Mustafa Rawaf
-
-
New Jersey
-
Marlton、New Jersey、美国、08053
- Hassman Research Institute Marlton Site
-
首席研究员:
- Elan Cohen
-
Toms River、New Jersey、美国、08755
- Bio Behavioral Health
-
首席研究员:
- Ashok Patel
-
-
New York
-
Cedarhurst、New York、美国、11516
- Neurobehavioral Research Inc
-
首席研究员:
- Ronald Brenner
-
Mount Kisco、New York、美国、10128
- Bioscience Research, LLC
-
首席研究员:
- David Krakow
-
New York、New York、美国、10029
- Adams Clinical Harlem
-
首席研究员:
- Rachel Noone
-
New York、New York、美国、10036
- IMA Clinical Research NYC Midtown
-
首席研究员:
- Eli Shalenberg
-
Staten Island、New York、美国、10314
- Richmond Behavioral Associates
-
首席研究员:
- Adam Smith
-
-
Pennsylvania
-
Allentown、Pennsylvania、美国、18103
- Lehigh Center for Clinical Research
-
首席研究员:
- Paul Gross
-
Philadelphia、Pennsylvania、美国、19104
- Adams Clinical Philadelphia
-
首席研究员:
- Cassie Blanchard
-
-
Texas
-
Austin、Texas、美国、78731
- IMA Clinical Research Austin - Northland
-
首席研究员:
- Charles Sweet
-
Dallas、Texas、美国、75243
- Lonestar Clinical Research
-
首席研究员:
- Lili Meisamy
-
DeSoto、Texas、美国、75115
- Adams Clinical Dallas
-
首席研究员:
- Benji Kurian
-
-
Virginia
-
Fairfax、Virginia、美国、22030
- Inspire Behavioral Health
-
首席研究员:
- Bhagwan Bahroo
-
-
Washington
-
Bellevue、Washington、美国、98007
- Northwest Clinical Research Center
-
首席研究员:
- Wisam Al jumaili
-
-
-
-
-
Doncaster、英国、DN4 8QN
- Clerkenwell Health - Doncaster
-
首席研究员:
- Ibreez Ajaz
-
Exeter、英国、EX2 5AF
- Devon Partnership Trust
-
首席研究员:
- Merryn Anderson
-
London、英国、W1U 6RP
- Clerkenwell Health - London - Baker Street
-
首席研究员:
- Alishah Suleman
-
London、英国、SE5 8AZ
- The Maudsley Hospital
-
首席研究员:
- Mario Juruena
-
-
-
-
-
's-Hertogenbosch、荷兰、5223 LA
- Brain Research Center Den Bosch B.V.
-
首席研究员:
- Roel Mocking
-
Amsterdam、荷兰、1081 GM
- Alzheimer's Research Center
-
首席研究员:
- Roel Mocking
-
Groningen、荷兰、9700 RB
- University Medical Center Groningen
-
首席研究员:
- Robert Schoevers
-
Leiden、荷兰、2333 ZA
- Leids Universitair Medisch Centrum
-
首席研究员:
- Nic van der Wee
-
Zwolle、荷兰、8025 AZ
- Brain Research Center Zwolle
-
首席研究员:
- Roel Mocking
-
-
-
-
-
Alcorcón、西班牙、28922
- Hospital Fundación Alcorcón
-
首席研究员:
- Francisco Montanes Rada
-
Barcelona、西班牙、08035
- Hospital Universitari Vall d'Hebron
-
首席研究员:
- Josep-Antoni Ramos-Quiroga
-
Madrid、西班牙、28022
- Clinica Universidad Navarra-Sede Madrid
-
首席研究员:
- Patricio Molero Santos
-
Salamanca、西班牙、37007
- Hospital Universitario de Salamanca - Complejo Asistencial Universitario de Salamanca
-
首席研究员:
- ANGEL MONTEJO
-
Valdemoro、西班牙、28342
- Hospital Universitario Infanta Elena
-
首席研究员:
- Enrique Baca-Garcia
-
Vigo、西班牙、36213
- Hospital Álvaro Cunqueiro
-
首席研究员:
- Jose Antonio Campos Perez
-
Zamora、西班牙、49022
- Hospital Virgen De La Concha
-
首席研究员:
- Juan Antonio Mellado
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
-
Have a diagnosis of Major Depressive Disorder (MDD) and are in a current major depressive episode, without psychotic features
-
Are on a stable antidepressant monotherapy regimen for the current major depressive episode
-
Are a partial responder to the current antidepressant monotherapy regimen
-
Are reliable and willing to make themselves available for the duration of the study and attend required study visits, and are willing and able to follow study procedures as required, such as:
- self-inject study intervention
- store and use the provided blinded study intervention, as directed
- maintain electronic and paper study diaries, as applicable, and
- complete the required questionnaires
Exclusion Criteria:
-
Have a lifetime history or current diagnosis of the following:
- schizophrenia or other psychotic disorder
- bipolar disorder
- borderline personality disorder
- other personality disorders that would interfere with compliance with the study protocol
- neurocognitive disorders or intellectual disability, or
- any eating disorder
-
Have type 1 diabetes mellitus, or a history of
- ketoacidosis, or
- hyperosmolar state or coma
-
Have had a history of any substance or alcohol use disorder of any severity within 180 days before Visit 1
-
Are actively suicidal or deemed a significant risk for suicide
-
Have participated in a clinical study and received active treatment, or unknown if they received active treatment, within 90 days or 5 half-lives (whichever is longer) before Visit 1
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:双倍的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Brenipatide
Brenipatide administered subcutaneously (SC) + standard of care (SoC) anti-depressant |
Administered SC
其他名称:
|
|
安慰剂比较:Placebo
Placebo administered SC + SoC anti-depressant |
Administered SC |
研究衡量的是什么?
主要结果指标
结果测量 |
大体时间 |
|---|---|
|
Change from Baseline in Montgomery-Asberg Depression Rating Scale (MADRS-9) Score
大体时间:Baseline, Week 10
|
Baseline, Week 10
|
次要结果测量
结果测量 |
大体时间 |
|---|---|
|
Change from Baseline in Hamilton Depression Rating Scale Score
大体时间:Baseline, Week 10
|
Baseline, Week 10
|
|
Change from Baseline in Sheehan Disability Scale (SDS) Global Functional Impairment Score
大体时间:Baseline, Week 10
|
Baseline, Week 10
|
|
Achievement of Body Weight Reduction ≥5% in Participants with a Baseline Body Mass Index (BMI) ≥25 kg/m²
大体时间:Baseline, Week 10
|
Baseline, Week 10
|
|
Number of Participants with Treatment-Emergent Anti-Drug Antibodies (ADA)
大体时间:Baseline, Up to Week 18
|
Baseline, Up to Week 18
|
合作者和调查者
调查人员
- 研究主任:Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST)、Eli Lilly and Company
研究记录日期
研究主要日期
学习开始 (估计的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- 27873
- J2S-MC-GZMW (其他标识符:Eli Lilly and Company)
- 2026-527689-65-00 (其他标识符:EU Trial (CTIS) Number)
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
IPD 计划说明
Anonymized individual patient level data will be provided in a secure access environment upon approval of a research proposal and a signed data sharing agreement.
IPD 共享时间框架
Data are available 6 months after the primary publication or approval of the indication studied in the US and European Union (EU), whichever is later. Data will be indefinitely available for requesting.
IPD 共享访问标准
A research proposal must be approved by an independent review panel and researchers must sign a data sharing agreement.
IPD 共享支持信息类型
- 研究方案
- 树液
- 企业社会责任
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.